Sanofi Statistics
Total Valuation
Sanofi has a market cap or net worth of 118.69 billion. The enterprise value is 127.08 billion.
Market Cap | 118.69B |
Enterprise Value | 127.08B |
Important Dates
The last earnings date was Thursday, July 31, 2025.
Earnings Date | Jul 31, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Current Share Class | 1.22B |
Shares Outstanding | n/a |
Shares Change (YoY) | -0.92% |
Shares Change (QoQ) | -1.36% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 1.10B |
Valuation Ratios
The trailing PE ratio is 11.07 and the forward PE ratio is 10.27.
PE Ratio | 11.07 |
Forward PE | 10.27 |
PS Ratio | 2.21 |
PB Ratio | 1.44 |
P/TBV Ratio | 5.83 |
P/FCF Ratio | 10.62 |
P/OCF Ratio | 9.01 |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 8.68, with an EV/FCF ratio of 11.37.
EV / Earnings | 11.86 |
EV / Sales | 2.38 |
EV / EBITDA | 8.68 |
EV / EBIT | 11.42 |
EV / FCF | 11.37 |
Financial Position
The company has a current ratio of 1.27, with a Debt / Equity ratio of 0.32.
Current Ratio | 1.27 |
Quick Ratio | 0.81 |
Debt / Equity | 0.32 |
Debt / EBITDA | 1.80 |
Debt / FCF | 2.34 |
Interest Coverage | 16.91 |
Financial Efficiency
Return on equity (ROE) is 9.00% and return on invested capital (ROIC) is 6.20%.
Return on Equity (ROE) | 9.00% |
Return on Assets (ROA) | 4.60% |
Return on Invested Capital (ROIC) | 6.20% |
Return on Capital Employed (ROCE) | 9.78% |
Revenue Per Employee | 648,117 |
Profits Per Employee | 129,317 |
Employee Count | 82,878 |
Asset Turnover | 0.36 |
Inventory Turnover | 1.30 |
Taxes
In the past 12 months, Sanofi has paid 1.80 billion in taxes.
Income Tax | 1.80B |
Effective Tax Rate | 19.24% |
Stock Price Statistics
The stock price has decreased by -6.69% in the last 52 weeks. The beta is 0.41, so Sanofi's price volatility has been lower than the market average.
Beta (5Y) | 0.41 |
52-Week Price Change | -6.69% |
50-Day Moving Average | 96.93 |
200-Day Moving Average | 102.28 |
Relative Strength Index (RSI) | 43.81 |
Average Volume (20 Days) | 105,927 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Sanofi had revenue of 53.71 billion and earned 10.72 billion in profits. Earnings per share was 8.65.
Revenue | 53.71B |
Gross Profit | 38.31B |
Operating Income | 11.02B |
Pretax Income | 9.38B |
Net Income | 10.72B |
EBITDA | 14.19B |
EBIT | 11.02B |
Earnings Per Share (EPS) | 8.65 |
Balance Sheet
The company has 18.04 billion in cash and 26.17 billion in debt, giving a net cash position of -8.13 billion.
Cash & Cash Equivalents | 18.04B |
Total Debt | 26.17B |
Net Cash | -8.13B |
Net Cash Per Share | n/a |
Equity (Book Value) | 82.54B |
Book Value Per Share | 67.55 |
Working Capital | 9.35B |
Cash Flow
In the last 12 months, operating cash flow was 13.17 billion and capital expenditures -1.99 billion, giving a free cash flow of 11.18 billion.
Operating Cash Flow | 13.17B |
Capital Expenditures | -1.99B |
Free Cash Flow | 11.18B |
FCF Per Share | n/a |
Margins
Gross margin is 71.32%, with operating and profit margins of 20.51% and 19.95%.
Gross Margin | 71.32% |
Operating Margin | 20.51% |
Pretax Margin | 17.46% |
Profit Margin | 19.95% |
EBITDA Margin | 26.42% |
EBIT Margin | 20.51% |
FCF Margin | 20.81% |
Dividends & Yields
Sanofi does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | 52.29% |
Buyback Yield | 0.92% |
Shareholder Yield | n/a |
Earnings Yield | 9.03% |
FCF Yield | 9.42% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | |
Lynch Upside | |
Graham Number | |
Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 7 |